Treatment of peritoneal metastases from gastric carcinoma
Patients with advanced gastric cancer and positive peritoneal cytology and/or peritoneal dissemination are deemed to be incurable and to hold dismal prognosis. So far, the only treatment option for these patients has been palliative systemic (chemo)therapy. However, for the last three decades, great...
主要な著者: | Polkowski Wojciech P., Rawicz-Pruszynski Karol, Mielko Jerzy, Geca Katarzyna, Skorzewska Magdalena, Cisel Bogumila |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Sciendo
2017-12-01
|
シリーズ: | Current Issues in Pharmacy and Medical Sciences |
主題: | |
オンライン・アクセス: | https://doi.org/10.1515/cipms-2017-0032 |
類似資料
-
Advances in surgery for peritoneal surface malignancies
著者:: Mielko Jerzy, 等
出版事項: (2017-12-01) -
Data on the quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies: does it concern patients with gastric cancer?
著者:: Skierucha Malgorzata, 等
出版事項: (2017-12-01) -
Diaphragmatic peritoneal metastases mimicking liver metastases
著者:: Noiret Barbara, 等
出版事項: (2021-08-01) -
Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer
著者:: Simkens GA, 等
出版事項: (2017-06-01) -
Cytoreductive Surgery and Hyperthermic İntraperitoneal Chemoterapy for Advance Gastric Cancer Associated Peritoneal Carcinomatosis Single Centre Unit for 10 Consecutive Patients
著者:: Özgül Düzgün, 等
出版事項: (2019-09-01)